Regeneron Pharmaceuticals REGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.12B+25.5% | $2.49B-9.1% | $2.74B-12.2% | $3.12B+7.6% | ||
| $5.49B-15.9% | $6.52B-19.6% | $8.11B+75.0% | $4.64B+65.0% | ||
| $5.74B-7.6% | $6.21B+9.6% | $5.67B+6.4% | $5.33B-11.7% | ||
| $3.2B+3.7% | $3.09B+19.6% | $2.58B+7.4% | $2.4B+23.1% | ||
| $18.02B-3.4% | $18.66B-4.2% | $19.48B+22.6% | $15.88B+13.3% | ||
| $40.56B+7.4% | $37.76B+14.1% | $33.08B+13.2% | $29.21B+14.9% | ||
| $939M+18.9% | $789.5M+30.2% | $606.6M+3.0% | $589.2M+4.5% | ||
| $553M-11.9% | $627.7M+36.8% | $458.9M-4.0% | $477.9M+8.1% | ||
| $4.37B+10.8% | $3.94B+15.2% | $3.42B+9.0% | $3.14B-20.1% | ||
| $1.99B+0.1% | $1.98B+0.1% | $1.98B+0.1% | $1.98B+0.1% | ||
| $9.3B+10.7% | $8.41B+18.3% | $7.11B+8.5% | $6.55B-1.7% | ||
| $35.8B+13.0% | $31.67B+16.2% | $27.26B+17.0% | $23.31B+22.9% | ||
| $31.26B+6.5% | $29.35B+13.0% | $25.97B+14.6% | $22.66B+20.8% | ||
| $40.56B+7.4% | $37.76B+14.1% | $33.08B+13.2% | $29.21B+14.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regeneron Pharmaceuticals's total assets?
- Regeneron Pharmaceuticals (REGN) holds $40.9B in total assets, up 8.8% year over year.
- How much debt does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals carries $2.7B in total debt against $31.4B of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals holds $3.0B in cash and equivalents.
- Can Regeneron Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.56 — current assets exceed current liabilities.
- Where does Regeneron Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Regeneron Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
